Silvant Capital Management’s Elevance Health ELV Stock Holding History

Silvant Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$100K	Hold	257	–	–	﹤0.01%	246
2026 Q2	$99.4K	Hold	257	–	–	﹤0.01%	249
2026 Q1	$75.2K	Hold	257	–	–	﹤0.01%	257
2025 Q4	$90.1K	Hold	257	–	–	﹤0.01%	235
2025 Q3	$83K	Hold	257	–	–	﹤0.01%	242
2025 Q2	$100K	Hold	257	–	–	﹤0.01%	221
2025 Q1	$112K	Hold	257	–	–	0.01%	215
2024 Q4	$94.8K	Hold	257	–	–	﹤0.01%	226
2024 Q3	$134K	Hold	257	–	–	0.01%	202
2024 Q2	$139K	Hold	257	–	–	0.01%	190
2024 Q1	$133K	Hold	257	–	–	0.01%	198
2023 Q4	$121K	Hold	257	–	–	0.01%	197
2023 Q3	$112K	Hold	257	–	–	0.01%	196
2023 Q2	$114K	Hold	257	–	–	0.01%	200
2023 Q1	$118K	Hold	257	–	–	0.01%	191
2022 Q4	$132K	Hold	257	–	–	0.01%	185
2022 Q3	$117K	Hold	257	–	–	0.01%	234
2022 Q2	$124K	Hold	257	–	–	0.03%	192
2022 Q1	$126K	Hold	257	–	–	0.02%	208
2021 Q4	$119K	Hold	257	–	–	0.02%	210
2021 Q3	$96K	Hold	257	–	–	0.02%	229
2021 Q2	$98K	Hold	257	–	–	0.02%	236
2021 Q1	$92K	Hold	257	–	–	0.02%	239
2020 Q4	$83K	Hold	257	–	–	0.01%	238
2020 Q3	$69K	Hold	257	–	–	0.01%	236
2020 Q2	$68K	Hold	257	–	–	0.01%	237
2020 Q1	$58K	Hold	257	–	–	0.01%	229
2019 Q4	$78K	Hold	257	–	–	0.01%	241
2019 Q3	$62K	Sell	257 -56	-18%	-$15.3K	0.01%	250
2019 Q2	$88K	Hold	313	–	–	0.02%	244
2019 Q1	$90K	Hold	313	–	–	0.02%	237
2018 Q4	$82K	Hold	313	–	–	0.02%	236
2018 Q3	$86K	Hold	313	–	–	0.01%	249
2018 Q2	$75K	Hold	313	–	–	0.01%	260
2018 Q1	$69K	Buy	+313	New	+$73.5K	0.01%	271

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Silvant Capital Management's ELV Position: Q3 2026 in Review

Silvant Capital Management held its Elevance Health (ELV) position steady in Q3 2026 at 257 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Silvant Capital Management first reported a position in ELV in Q1 2018 and has held it in 35 quarters since. The position peaked at $139K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Silvant Capital Management held 257 shares of Elevance Health worth $100K as of Q3 2026.
Silvant Capital Management left its Elevance Health share count unchanged in Q3 2026.
Elevance Health made up ﹤0.01% of Silvant Capital Management's portfolio in Q3 2026, its #246 holding.
Silvant Capital Management first reported a position in Elevance Health in Q1 2018 and has held it in 35 quarters since.
Silvant Capital Management's Elevance Health position peaked at $139K in Q2 2024.
1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Silvant Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.